EP 1536789 A1 20050608 - MEDICAMENT CONTAINING DISORAZOLES AND DERIVATIVES THEREOF FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMORAL DISEASES
Title (en)
MEDICAMENT CONTAINING DISORAZOLES AND DERIVATIVES THEREOF FOR THE TREATMENT OF BENIGN AND MALIGNANT TUMORAL DISEASES
Title (de)
ARZNEIMITTEL ENTHALTEND DISORAZOLE UND IHRE DERIVATE UND DEREN ANWENDUNG ZUR BEHANDLUNG GUTARTIGER UND BÖSARTIGER TUMORERKRANKUNGEN
Title (fr)
UTILISATION DE DISORAZOLES ET DE LEURS DERIVES POUR TRAITER DES TUMEURS BENIGNES OU MALIGNES
Publication
Application
Priority
- EP 0309329 W 20030822
- US 40559402 P 20020824
Abstract (en)
[origin: WO2004024149A1] The invention relates to disorazoles of general formula (1) which are used as medicaments, preferably in the treatment of tumoral diseases, especially in the case of medicamentous resistance against other active ingredients and in metastasing carcinoma. Possible uses thereof are not restricted to tumoral diseases.
IPC 1-7
IPC 8 full level
A61K 31/424 (2006.01); C07D 498/18 (2006.01); C07D 498/22 (2006.01)
CPC (source: EP KR US)
A61K 31/424 (2013.01 - EP KR US); A61P 1/00 (2017.12 - EP); A61P 3/14 (2017.12 - EP); A61P 5/50 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 11/02 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 17/04 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 17/12 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 27/14 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 33/00 (2017.12 - EP); A61P 33/06 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/08 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 498/18 (2013.01 - EP US); C07D 498/22 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)
Citation (search report)
See references of WO 2004024149A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated extension state (EPC)
LT LV MK
DOCDB simple family (publication)
WO 2004024149 A1 20040325; AR 042617 A1 20050629; AU 2003296872 A1 20040430; AU 2003296872 B2 20080214; BR 0313789 A 20050705; CA 2438001 A1 20040224; CN 1678310 A 20051005; EP 1536789 A1 20050608; HR P20050277 A2 20050430; IL 166588 A0 20060115; JP 2006500398 A 20060105; KR 20050038632 A 20050427; MX PA05002157 A 20050523; NO 20051444 L 20050519; NZ 538926 A 20060331; PL 376407 A1 20051227; RU 2005108570 A 20050827; RU 2322236 C2 20080420; TW 200404537 A 20040401; UA 79480 C2 20070625; US 2004106662 A1 20040603; US 2009311264 A1 20091217; ZA 200501196 B 20051026
DOCDB simple family (application)
EP 0309329 W 20030822; AR P030103050 A 20030822; AU 2003296872 A 20030822; BR 0313789 A 20030822; CA 2438001 A 20030822; CN 03820093 A 20030822; EP 03794920 A 20030822; HR P20050277 A 20050323; IL 16658805 A 20050131; JP 2004535140 A 20030822; KR 20057003109 A 20050223; MX PA05002157 A 20030822; NO 20051444 A 20050318; NZ 53892603 A 20030822; PL 37640703 A 20030822; RU 2005108570 A 20030822; TW 92123217 A 20030822; UA 2005001355 A 20030822; US 26398109 A 20090407; US 64690403 A 20030822; ZA 200501196 A 20050210